Bio­gen's shake­up from the top; How to build a biotech to­day; David Saba­ti­ni backs out of NYU; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

Good­byes are hard, es­pe­cial­ly when it comes to send­ing off a dear friend and col­league like Ja­son Mast, who’s leav­ing End­points. I have had the hon­or of be­ing the first to read many of his sto­ries — of­ten in equal parts in­ci­sive and in­trigu­ing — and am tru­ly thank­ful for the many ways he’s shaped the team for the bet­ter. We’ll all miss him but are al­so ex­cit­ed to see what his next chap­ter brings.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER